End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
189,000 KRW | +2.89% | +5.76% | -6.20% |
Apr. 24 | Market Share of Celltrion’s Remsima Rises to 74% in Europe | MT |
Apr. 17 | Celltrion, Inc. announces an Equity Buyback for 436,047 shares. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.20% | 28.31B | |
-0.31% | 42.19B | |
+44.30% | 40.15B | |
+5.46% | 24.63B | |
-24.09% | 18.2B | |
+26.64% | 12.01B | |
-3.62% | 11.76B | |
+12.90% | 10.4B | |
-3.10% | 9.94B | |
-5.57% | 9.39B |
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion's Autoimmune Disease Treatment Hits US Markets